Uremic Syndrome: Systemic Manifestations and Current Criteria for Dialytic Therapy Initiation.

Authors

DOI:

https://doi.org/10.36557/2674-8169.2026v8n2p382-397

Keywords:

Uremia; Chronic Kidney Failure; Renal Dialysis; Renal Replacement Therapy; Uremic Toxins.

Abstract

Introduction: Uremic syndrome is interpreted as a systemic condition caused by the retention of uremic solutes and the loss of excretory and regulatory functions in advanced chronic kidney disease. Objective: To describe the systemic manifestations of uremic syndrome and summarize the current criteria for initiating dialytic therapy. Methodology: A scoping review was conducted on PubMed/MEDLINE using MeSH searches and free text on uremia, uremic toxins, systemic manifestations, and "dialysis initiation," excluding hemolytic uremic syndrome. The period considered was 2016–2025, including guidelines, consensus documents, reviews, and observational studies in humans; the selection was made based on title/abstract and full text, with standardized extraction and thematic synthesis. Results: Nineteen high-quality publications were included. The evidence agreed that the initiation of dialysis should not be defined by an isolated eGFR threshold but by uremic symptoms and refractory complications, such as volume overload, functional impairment, neurological manifestations, severe itching, and pericarditis, among others. In older adults, starting dialysis was associated with modest survival gains and reduced "home time," supporting shared decisions based on care goals and individual preferences. Conclusion: Uremic syndrome is better approached as a syndromic and person-centered framework; dialytic therapy is indicated when the symptomatic burden or complications are clinically significant and uncontrollable with medical treatment.

Downloads

Download data is not yet available.

References

Meijers B, Zadora W, Lowenstein J. A Historical Perspective on Uremia and Uremic Toxins. Toxins (Basel). 2024; 16(5):227.

Vanholder R, Snauwaert E, Verbeke F, Glorieux G. Future of Uremic Toxin Management. Toxins [Internet]. Multidisciplinary Digital Publishing Institute; 2024; 16(11):463. Available from: https://www.mdpi.com/2072-6651/16/11/463.

Cozzolino M, Magagnoli L, Ciceri P. From Physicochemical Classification to Multidimensional Insights: A Comprehensive Review of Uremic Toxin Research. Toxins (Basel). 2025; 17(6):295.

Wojtaszek E, Oldakowska-Jedynak U, Kwiatkowska M, Glogowski T, Malyszko J. Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation. Oxid Med Cell Longev. 2021; 2021:6651367.

Valkenburg S, Glorieux G, Vanholder R. Uremic Toxins and Cardiovascular System. Cardiol Clin. 2021; 39(3):307–18.

Chermiti R, Burtey S, Dou L. Role of Uremic Toxins in Vascular Inflammation Associated with Chronic Kidney Disease. J Clin Med. 2024; 13(23):7149.

Garikapati K, Goh D, Khanna S, Echampati K. Uraemic Cardiomyopathy: A Review of Current Literature. Clin Med Insights Cardiol. 2021; 15:1179546821998347.

Rosner MH, Husain-Syed F, Reis T, Ronco C, Vanholder R. Uremic encephalopathy. Kidney Int. 2022; 101(2):227–41.

Bossola M, Picconi B. Uremic toxins and the brain in chronic kidney disease. J Nephrol. 2024; 37(5):1391–5.

Badura K, Janc J, Wąsik J, Gnitecki S, Skwira S, Młynarska E, et al. Anemia of Chronic Kidney Disease-A Narrative Review of Its Pathophysiology, Diagnosis, and Management. Biomedicines. 2024; 12(6):1191.

Baaten CCFMJ, Sternkopf M, Henning T, Marx N, Jankowski J, Noels H. Platelet Function in CKD: A Systematic Review and Meta-Analysis. J Am Soc Nephrol. 2021; 32(7):1583–98.

Makar M, Smyth B, Brennan F. Chronic Kidney Disease-Associated Pruritus: A Review. Kidney Blood Press Res. 2021; 46(6):659–69.

Zibandeh N, Li Z, Ogg G, Bottomley MJ. Cutaneous adaptive immunity and uraemia: a narrative review. Front Immunol. 2024; 15:1464338.

Williams MJ, White SC, Joseph Z, Hruska KA. Updates in the chronic kidney disease-mineral bone disorder show the role of osteocytic proteins, a potential mechanism of the bone-Vascular paradox, a therapeutic target, and a biomarker. Front Physiol. 2023; 14:1120308.

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024; 105(4S):S117–314.

Salas-Gama K, Onakpoya IJ, Coronado Daza J, Perera R, Heneghan CJ. Recommendations of high-quality clinical practice guidelines related to the process of starting dialysis: A systematic review. PLoS One [Internet]. 2022; 17(6):e0266202. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9191707/.

Jia X, Tang X, Li Y, Xu D, Moreira P. Update of dialysis initiation timing in end stage kidney disease patients: is it a resolved question? A systematic literature review. BMC Nephrol. 2023; 24(1):162.

Rooij ENM de, Meuleman Y, Fijter JW de, Jager KJ, Chesnaye NC, Evans M, et al. Symptom Burden before and after Dialysis Initiation in Older Patients. Clin J Am Soc Nephrol. 2022; 17(12):1719–29.

Montez-Rath ME, Thomas I-C, Charu V, Odden MC, Seib CD, Arya S, et al. Effect of Starting Dialysis Versus Continuing Medical Management on Survival and Home Time in Older Adults With Kidney Failure : A Target Trial Emulation Study. Ann Intern Med. 2024; 177(9):1233–43.

Husain-Syed F, Vanholder R, Rosner MH, Kawanishi H, Sirich TL, Ronco C. Critical Appraisal of Limitations in the Current Definition/Classification of Uremic Toxins. Blood Purif. 2023; 52(3):221–32.

Skrzypczak T, Skrzypczak A, Nockowski P, Szepietowski JC. Identification and Management of CKD-Associated Pruritus: Current Insights. Int J Nephrol Renovasc Dis. 2024; 17:339–54.

Mehrotra R, Davison SN, Farrington K, Flythe JE, Foo M, Madero M, et al. Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023; 104(3):441–54.

Dad T, Sarnak MJ. Pericarditis and Pericardial Effusions in End-Stage Renal Disease. Semin Dial. 2016; 29(5):366–73.

Chan CT, Blankestijn PJ, Dember LM, Gallieni M, Harris DCH, Lok CE, et al. Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019; 96(1):37–47.

Fu EL, Evans M, Carrero J-J, Putter H, Clase CM, Caskey FJ, et al. Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study. BMJ. Clinical research ed.; 2021; 375:e066306.

Mathur VS, Wesson DE, Li E, Tangri N. Factors Affecting the Decision to Initiate Dialysis: A National Survey of United States Nephrologists. Am J Nephrol. 2022; 53(10):722–9.

Published

2026-02-09

How to Cite

Idrovo Chiriboga, V. K., & Idrovo Chiriboga, B. F. (2026). Uremic Syndrome: Systemic Manifestations and Current Criteria for Dialytic Therapy Initiation. Brazilian Journal of Implantology and Health Sciences, 8(2), 382–397. https://doi.org/10.36557/2674-8169.2026v8n2p382-397